-
Je něco špatně v tomto záznamu ?
Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking
A. Imramovsky, S. Stepankova, J. Vanco, K. Pauk, J. Monreal-Ferriz, J. Vinsova, J. Jampilek,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- acetylcholinesterasa metabolismus MeSH
- cholinesterasové inhibitory chemie farmakologie MeSH
- Electrophorus metabolismus MeSH
- fenylkarbamáty metabolismus MeSH
- galantamin metabolismus MeSH
- karbamáty chemie farmakologie MeSH
- katalytická doména MeSH
- molekulární modely MeSH
- salicylanilidy chemie farmakologie MeSH
- simulace molekulového dockingu MeSH
- vazebná místa MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A series of twenty-five novel salicylanilide N-alkylcarbamates were investigated as potential acetylcholinesterase inhibitors. The compounds were tested for their ability to inhibit acetylcholinesterase (AChE) from electric eel (Electrophorus electricus L.). Experimental lipophilicity was determined, and the structure-activity relationships are discussed. The mode of binding in the active site of AChE was investigated by molecular docking. All the discussed compounds expressed significantly higher AChE inhibitory activity than rivastigmine and slightly lower than galanthamine. Disubstitution by chlorine in C'(₃,₄) of the aniline ring and the optimal length of hexyl-undecyl alkyl chains in the carbamate moiety provided the most active AChE inhibitors. Monochlorination in C'(₄) exhibited slightly more effective AChE inhibitors than in C'(₃). Generally it can be stated that compounds with higher lipophilicity showed higher inhibition, and the activity of the compounds is strongly dependent on the length of the N-alkyl chain.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012511
- 003
- CZ-PrNML
- 005
- 20130411115450.0
- 007
- ta
- 008
- 130404s2012 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules170910142 $2 doi
- 035 __
- $a (PubMed)22922284
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Imramovsky, Ales $u Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 53210 Pardubice, Czech Republic. ales.imramovsky@upce.cz
- 245 10
- $a Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking / $c A. Imramovsky, S. Stepankova, J. Vanco, K. Pauk, J. Monreal-Ferriz, J. Vinsova, J. Jampilek,
- 520 9_
- $a A series of twenty-five novel salicylanilide N-alkylcarbamates were investigated as potential acetylcholinesterase inhibitors. The compounds were tested for their ability to inhibit acetylcholinesterase (AChE) from electric eel (Electrophorus electricus L.). Experimental lipophilicity was determined, and the structure-activity relationships are discussed. The mode of binding in the active site of AChE was investigated by molecular docking. All the discussed compounds expressed significantly higher AChE inhibitory activity than rivastigmine and slightly lower than galanthamine. Disubstitution by chlorine in C'(₃,₄) of the aniline ring and the optimal length of hexyl-undecyl alkyl chains in the carbamate moiety provided the most active AChE inhibitors. Monochlorination in C'(₄) exhibited slightly more effective AChE inhibitors than in C'(₃). Generally it can be stated that compounds with higher lipophilicity showed higher inhibition, and the activity of the compounds is strongly dependent on the length of the N-alkyl chain.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a karbamáty $x chemie $x farmakologie $7 D002219
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a cholinesterasové inhibitory $x chemie $x farmakologie $7 D002800
- 650 _2
- $a Electrophorus $x metabolismus $7 D004593
- 650 _2
- $a galantamin $x metabolismus $7 D005702
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a fenylkarbamáty $x metabolismus $7 D048448
- 650 _2
- $a salicylanilidy $x chemie $x farmakologie $7 D012458
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Stepankova, Sarka $u -
- 700 1_
- $a Vanco, Jan $u -
- 700 1_
- $a Pauk, Karel $u -
- 700 1_
- $a Monreal-Ferriz, Juana $u -
- 700 1_
- $a Vinsova, Jarmila $u -
- 700 1_
- $a Jampilek, Josef $u -
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 17, č. 9 (2012), s. 10142-58
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22922284 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130411115721 $b ABA008
- 999 __
- $a ok $b bmc $g 975709 $s 810792
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 17 $c 9 $d 10142-58 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20130404